Research suggests that the available studies linked here do not provide meaningful evidence specifically examining garlic in food form as a tool for cancer risk reduction. The four studies included cover topics such as genetic influences on metabolomics data, supplement use and COVID-19 infection risk, metabolic changes following weight loss in type 2 diabetes, and lifestyle changes in older adults during pandemic lockdowns — none of which directly investigate garlic consumption and cancer outcomes. The one study that does mention garlic, a large observational study of over 1.4 million app users, found no significant association between garlic supplement use and reduced infection risk, and it did not address cancer at all. Based on the studies provided, no conclusions can be drawn about garlic in food form and cancer risk reduction, and readers interested in this topic would need to consult research that directly addresses this question.
Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.
| Title | Type | Year | Direction | Match |
|---|---|---|---|---|
| Genome-wide Association Studies of Missing Metabolite Measures: Results From ... | Other | 2024 | Neutral | 90 |
| Dietary supplements during the COVID-19 pandemic: insights from 1.4M users of... | Other | 2020 | Neutral | 85 |
| The metabolomic signature of weight loss in the Diabetes Remission Clinical T... | Other | 2022 | Neutral | 80 |
| Changes in health behaviors, mental and physical health among older adults un... | Other | 2021 | Neutral | 75 |